One day after releasing Brandon Deaderick, the Patriots dropped another veteran from their defensive line. This decision, however, apparently was triggered by an off-field concern.
Kyle Love, recently diagnosed with Type-2 diabetes, was released by the team Wednesday afternoon. His agents, Sean Stellato and Richard Kopelman of Klass Sports, told various media outlets that they were told by the team the move was prompted by the disease, which caused Love to lose 20 pounds before he was diagnosed.
However, the agents say Love is treating his diabetes with diet and exercise, has regained 10 of the pounds he lost, and should be ready to play when training camp begins.
“This is type 2 diabetes," Kopelman told Jeff Howe of the Boston Herald, "which is generally thought to be easily managed . . . and not something that would interfere with a professional athlete’s career."
According to USA Today's Mike Garafolo, Love is "shocked" and going over his options to see if he may be able to file a grievance against the Patriots for releasing him on account of his diabetes diagnosis.
“I was assured this was pure and simple a medical decision,” Kopelman said. “I asked, ‘Was there something else at play here?’ And I was told no, it’s 100 percent a medical decision, and that’s all there is to it.”
Love attended Mississippi State and went undrafted but was signed by New England in 2010. He played three seasons for the Patriots and had 65 tackles and 5.5 sacks over that period.
The move comes on the heels of the Patriots release of Deaderick earlier this week. Now, along with Vince Wilfork, the Patriots have offseason additions Tommy Kelly and Armond Armstead on the roster at defensive tackle. They also have signed undrafted free agent defensive tackles Cory Grissom, Joe Vellano and Dwayne Cherington.